Norwegian scientist admits more cheating

January 23, 2006

A Norwegian researcher who started a scandal by admitting fabricating an article in the medical journal The Lancet has admitted additional cheating.

Dr. Jon Sudbo admitted fabricating articles in two other journals. All three articles concerned cancers of the mouth.

Sudbo's lawyer, Erling Lyngtveit, told Aftenposten his client regrets the medical bluff he maintained for several years and will cooperate with investigations concerning he and his employer, the national cancer hospital in Oslo.

Sudbo's fabrication of medical research also shocked researchers in the United States, where Sudbo worked with some of the world's top cancer scientists. Several of them had been listed as co-authors of the articles Sudbo admits fabricating.

The other articles Sudbo admits were phony were published in The New England Journal of Medicine in 2004 and in the Journal of Clinical Oncology last March. He admits fabricating fatality statistics in the first article and cheating on blood test data in the second article, Aftenposten reported.

Lyngtveit said none of the fraudulent articles has had consequences for patients and all other data and studies Sudbo presented are genuine.

Copyright 2006 by United Press International

Related Stories

Recommended for you

Amazon deforestation leaps 16 percent in 2015

November 28, 2015

Illegal logging and clearing of Brazil's Amazon rainforest increased 16 percent in the last year, the government said, in a setback to the aim of stopping destruction of the world's greatest forest by 2030.

CERN collides heavy nuclei at new record high energy

November 25, 2015

The world's most powerful accelerator, the 27 km long Large Hadron Collider (LHC) operating at CERN in Geneva established collisions between lead nuclei, this morning, at the highest energies ever. The LHC has been colliding ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.